A carregar...
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
Pancreatic cancer is the fourth leading cause of cancer death in the US and is expected to become the second leading cause of cancer-related deaths in the next decade. Despite 5-fluorouracil/leucovorin with irinotecan and oxaliplatin (FOLFIRINOX) and gemcitabine/nab-paclitaxel significantly improvin...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4500614/ https://ncbi.nlm.nih.gov/pubmed/26185420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S60328 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|